At APSL, we have a well-experienced team that is skilled with global quality and regulatory guidelines to complement your projects with the right set of analytical activities. We have a state-of-the-art analytical lab through which we can develop a variety of analytical methods. We plan the analytical strategy based on the project lifecycle and customer needs. We have capabilities across method verification, development, validation and impurity profiling that includes isolation, identification & characterization and assessment of nitrosamine or other genotoxic impurities. We also conduct stability studies as per ICH guidelines.
Equipments & Techniques
Chromatography Equipments
- HPLC instruments coupled with UV, PDA, ELSD, CAD and RI detectors with Empower 3 software
- GC instruments FID, TCD, ECD detectors with Empower 3 software
- UPLC instruments
- Ion Chromatography
Advanced Characterization techniques
Mass spectrometer (LC-MS and HR-MS)
- AB Sciex 4500 QQQ instrument
- Waters UPLC with LCT premier XE Time of flight detector
- Agilent HPLC with 6410 triple quad mass detectors
- Agilent GC with 5975C EI/CI Inert XL detector
- UV-Visible spectrophotometer
- FT- IR with UATR
- 400 MHz NMR spectroscopy
- Elemental impurities: Agilent 7800 ICPMS
Solid State Characterization Techniques
- DSC and TGA instruments
- Particle size analyzer: Malvern Master sizer 3000
- Headspace Coulometer, Karl Fischer Analyzer
Preparative Chromatography
- Semi Preparative Instruments
- Preparative Scale Instruments
- Flash Chromatography
- Gel Permeation Chromatography
- Ion Exchange Chromatography
- Bench-Top Lyophilizer
Early phase
For early phase projects, we develop analytical methods in hand-in-hand with the process development program. For critical quality attributes of the final product such as assay, related substances, and residual solvents analytical methods are verified. Our standard analytical method verification procedures check LOD, LOQ, linearity, precision, specificity, accuracy, robustness, solution stability, and mobile phase stability. Along with these verifications, fit-for-purpose analytical methods for testing raw materials, in-process controls, and intermediate analysis are developed. Post mapping of equipment at the manufacturing facility, an appropriate residue method is also developed and validated. We generate and qualify the appropriate quantity of reference standards to support the analysis and method transfers.
Typical characterization of the reference standard includes
- Characterization with appropriate spectroscopic techniques, Mass spectrometry, NMR, and FT-IR
- Testing for its impurities (related substances / chromatographic purity) as per the pre-defined test procedure
- Water by KF or loss on drying
- Other parameters such as sulphated ash/residue on ignition (ROI) / residual solvents
- Determination of the potency of the reference standard
- The polymorphic characteristics of the material will be analyzed if it is a specific polymorph
Late phase
We perform method validation as per the internal SOP of APSL against the predefined specification. The method will be validated as per ICH guidelines for parameters like LOD, LOQ, linearity, repeatability, recovery, solution stability, specificity, precision, accuracy, robustness, and mobile phase stability. Analytical activities also depend on whether we are working on intermediates, RSM, or the final API.
- RSMs - Analytical methods will be developed for the Regulatory Starting Materials (RSMs) and those methods will be validated. The key tests for the KSM would be related substances, assay, and residual solvents along with the general tests such as appearance, Identification, water content, etc.
- For Intermediates - For the process validation campaign, analytical method validation for the intermediate stages required was followed by formal method transfer to the quality control site. Hence, we perform the complete method validation against predefined specifications and protocol and a report shall be created as per internal SOPs.
- For API - Analytical methods for the final API step would be validated before the start of manufacturing batches.
We also do the following analytical activities
- Forced degradation study - Specificity of the analytical test procedure will be demonstrated by various stress studies for the final compound in line with ICH guidelines by subjecting the sample to acid, base, peroxide, thermal, and photolytic degradation conditions, and a separate report will be generated for the forced degradation studies.
- Verification for pharmacopeia methods shall be done for identification tests like 1H NMR, 13C NMR, FT-IR, PXRD, DSC test, and water content by KF to confirm the identity test.
- Post mapping of equipment train at the manufacturing facility, appropriate residue method will be developed and validated.
- To support the analysis and method transfers, an appropriate quantity of the reference standard would be generated and qualified.
- Developing sensitive analytical methodology for Potential Genotoxic Impurities (PGI), Nitrosamines, Elemental impurities etc.
- Typical characterization of the reference standard includes:
- Characterization with appropriate spectroscopic techniques, Mass, NMR, and FT-IR
- Testing for its impurities (related substances / chromatographic purity) as per the pre-defined test procedure
- Water by KF or loss on drying
- Other parameters such as sulfated ash/residue on ignition (ROI) / residual solvents
- Determination of the potency of the reference standard
- The polymorphic characteristics of the material will be analyzed if it is a specific polymorph
Method validation and stability studies
We perform analytical validation in compliance with the Pharmacopoeia, current Good Manufacturing Practices (cGMP) & ICH requirements as per customer needs. Following are the salient features of our method validation activities:
- Method validation executed as per the well-defined phase appropriate SOPs which are in line with the current regulatory, ICH guidelines in accordance to cGMP requirements
- Our method validation capability includes KSMs, intermediates, APIs and drug product. SOPs are well defined to suit the phase specification method validation requirements
- Custom-field calculations, e-sign off procedures are enabled for chromatographic instruments to ensure the highest level of compliance.
- Validation activities recorded in to electronic lab notebook enforces online documentation in accordance to principles of ALCOA+
- Completion of validation to meeting stringent timelines
- Method transfer to QC
Stability studies:
We perform stability studies for developmental APIs, intermediates, RSMs and drug products.
- Stability studies as per ICH – Long term, Intermediate and Accelerated condition
- Short term temperature exposure studies
- Photo stability studies
We have the stability chambers, refrigerator and deep fridge storage suiting to requirements of different climatic zone.
Why Aurigene Analytical Method Development and Validation Services?
Expertise in global quality & regulatory guidelines
Phase appropriate standard operating procedures
Dedicated infrastructure
Breadth of analytical services
Expertise in the niche analytical requirements for various technology classes
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Methoxy Polyethylene Glycol (m-PEGs)
Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...
Read More
Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones
2020
A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...
Read More-
Ultrasound assisted rapid synthesis of mefenamic acid based indole derivatives under ligand free Cu-catalysis: Their pharmacological evaluation
2005
An improved and rapid synthesis of mefenamic acid based indole derivatives has been achieved via the ligand free Cu-catalyzed coupling-cyclization method under ultrasound irradiation. This simple, straightforward and inexpensive one-pot method involved the reaction of a terminal alkyne derived from mefenamic acid with 2- iodosulfanilides in the presence of CuI ...
Read More -
Formal synthesis of Cladospolide C & epi-Cladospolide C using R- (þ)-g-valerolactone as a chiral synthon
2005
The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...
Read More -
Amberlite-15 promoted an unprecedented aza Michael rearrangement for one pot synthesis of dihydroquinazolinone compounds
2005
A new one pot multicomponent annulation strategy for the synthesis of various dihydroquinazolinone compounds has been developed using Amberlite-15 as a catalyst, giving good to moderate yields. In this reaction the substrate scope for amines and aldehydes was also investigated. The reaction has been checked on a large scale ...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market